(2,4-Dichloropyrimidin-5-yl)methanol, 97%, 100mg

(S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid, 95.0%, 25g

N-(5-Aminopentyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 99.40%, 250mg

4-Methylsulphanylpiperidine hydrochloride, 98.0%, 10g

(2S,5S)-tert-butyl 5-(3-bromo-5-((diethoxyphosphoryl)methyl)benzyl)-2-(tert-butyl)-3-methyl-4-oxoimidazolidine-1-carboxylate, 98%, 250mg

4-ethyl-2-hydrazino-1,3-benzothiazole, 95.0%, 1g

5-Amino-2-chloroisonicotinic acid, 95.0%, 10g

Capillare per punto di fusione, 75 mm, 1.35 mm, 0.95 mm, 1000 Pezzo(i)

5-Amino-1-(3-methylphenyl)-1H-1,2,3-triazole-4-carboxamide, 95.0%, 500mg

N,n-methylenebismethacrylamide, 96%, 1g

2-(4-Fluorophenoxy)ethanamine hydrochloride, 95.0%, 5g

2-Oxo-1,2-dihydro-quinoline-3-carbaldehyde, 95.0%, 25g

Ethyl 7-Bromoimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 10g